Association between matrix metalloproteinase (MMP)-2, MMP-9 and total antioxidant status of patients with asymptomatic hepatitis C virus infection
Authors:
Open Access
- 11 July 2013
- journal article
- research article
- Published by Wiley in Letters in Applied Microbiology
- Vol. 57 (5) , 436-442
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Risk Factors for the Transmission of Hepatitis C Virus Infection in the Turkish PopulationDigestive Diseases and Sciences, 2006
- Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infectionClinica Chimica Acta, 2005
- The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer CellsThe American Journal of Pathology, 2005
- Hepatitis intensified oxidative stress, MIP-1β and RANTES plasma levels in uraemic patientsCytokine, 2004
- Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?British Journal of Pharmacology, 2004
- Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their QuantificationToxicologic Pathology, 2002
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001
- Hepatitis C Virus Genotypes and Risk of Cirrhosis in Southern ItalyClinical Infectious Diseases, 2001
- Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis CJournal of Hepatology, 1997
- A Novel Method for Measuring Antioxidant Capacity and its Application to Monitoring the Antioxidant Status in Premature NeonatesClinical Science, 1993